Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

NEM vs LIN vs ALB vs ECL

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
NEM
Newmont Corporation

Gold

Basic MaterialsNYSE • US
Market Cap$127.53B
5Y Perf.+96.9%
LIN
Linde plc

Chemicals - Specialty

Basic MaterialsNASDAQ • GB
Market Cap$232.56B
5Y Perf.+148.0%
ALB
Albemarle Corporation

Chemicals - Specialty

Basic MaterialsNYSE • US
Market Cap$22.70B
5Y Perf.+151.7%
ECL
Ecolab Inc.

Chemicals - Specialty

Basic MaterialsNYSE • US
Market Cap$74.40B
5Y Perf.+23.9%

NEM vs LIN vs ALB vs ECL — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
NEM logoNEM
LIN logoLIN
ALB logoALB
ECL logoECL
IndustryGoldChemicals - SpecialtyChemicals - SpecialtyChemicals - Specialty
Market Cap$127.53B$232.56B$22.70B$74.40B
Revenue (TTM)$17.23B$34.66B$5.49B$16.08B
Net Income (TTM)$5.26B$7.13B$-275M$2.08B
Gross Margin52.1%46.0%18.5%44.5%
Operating Margin49.3%28.8%5.6%17.7%
Forward P/E11.0x28.1x21.7x31.5x
Total Debt$474M$26.99B$3.30B$9.43B
Cash & Equiv.$7.65B$5.06B$1.62B$646M

NEM vs LIN vs ALB vs ECLLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

NEM
LIN
ALB
ECL
StockMay 20May 26Return
Newmont Corporation (NEM)100196.9+96.9%
Linde plc (LIN)100248.0+148.0%
Albemarle Corporati… (ALB)100251.7+151.7%
Ecolab Inc. (ECL)100123.9+23.9%

Price return only. Dividends and distributions are not included.

Quick Verdict: NEM vs LIN vs ALB vs ECL

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: NEM leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Linde plc is the stronger pick specifically for capital preservation and lower volatility and dividend income and shareholder returns. ALB also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
NEM
Newmont Corporation
The Growth Play

NEM carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.

  • Rev growth 19.1%, EPS growth 124.1%, 3Y rev CAGR 22.7%
  • Lower volatility, beta 0.75, Low D/E 1.4%, current ratio 1.72x
  • PEG 0.86 vs LIN's 1.11
  • 19.1% revenue growth vs ALB's -4.4%
Best for: growth exposure and sleep-well-at-night
LIN
Linde plc
The Income Pick

LIN is the #2 pick in this set and the best alternative if income & stability and long-term compounding is your priority.

  • Dividend streak 6 yrs, beta 0.24, yield 1.2%
  • 376.9% 10Y total return vs NEM's 271.4%
  • Beta 0.24, yield 1.2%, current ratio 0.88x
  • Beta 0.24 vs ALB's 1.60
Best for: income & stability and long-term compounding
ALB
Albemarle Corporation
The Momentum Pick

ALB is the clearest fit if your priority is momentum.

  • +237.9% vs ECL's +5.4%
Best for: momentum
ECL
Ecolab Inc.
The Lower-Volatility Pick

ECL lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: basic materials exposure
See the full category breakdown
CategoryWinnerWhy
GrowthNEM logoNEM19.1% revenue growth vs ALB's -4.4%
ValueNEM logoNEMLower P/E (11.0x vs 31.5x)
Quality / MarginsNEM logoNEM30.5% margin vs ALB's -5.0%
Stability / SafetyLIN logoLINBeta 0.24 vs ALB's 1.60
DividendsLIN logoLIN1.2% yield, 6-year raise streak, vs ALB's 0.8%
Momentum (1Y)ALB logoALB+237.9% vs ECL's +5.4%
Efficiency (ROA)NEM logoNEM9.4% ROA vs ALB's -1.7%, ROIC 24.9% vs 0.6%

NEM vs LIN vs ALB vs ECL — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

NEMNewmont Corporation
FY 2025
Gold Dore
63.2%$14.3B
Sales From Concentrate And Other Production
36.8%$8.3B
LINLinde plc
FY 2025
Americas Segment
45.9%$15.2B
EMEA Segment
25.8%$8.5B
APAC Segment
20.1%$6.7B
Engineering Segment
8.2%$2.7B
ALBAlbemarle Corporation
FY 2025
Energy Storage
52.7%$2.7B
Specialties
26.6%$1.4B
Ketjen
20.7%$1.1B
ECLEcolab Inc.
FY 2025
Global Water
49.6%$8.0B
Global Institutional and Specialty
38.0%$6.1B
Global Pest Elimination
7.8%$1.2B
Global Life Sciences
4.7%$748M

NEM vs LIN vs ALB vs ECL — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLNEMLAGGINGECL

Income & Cash Flow (Last 12 Months)

NEM leads this category, winning 4 of 6 comparable metrics.

LIN is the larger business by revenue, generating $34.7B annually — 6.3x ALB's $5.5B. NEM is the more profitable business, keeping 30.5% of every revenue dollar as net income compared to ALB's -5.0%. On growth, ALB holds the edge at +32.7% YoY revenue growth, suggesting stronger near-term business momentum.

MetricNEM logoNEMNewmont Corporati…LIN logoLINLinde plcALB logoALBAlbemarle Corpora…ECL logoECLEcolab Inc.
RevenueTrailing 12 months$17.2B$34.7B$5.5B$16.1B
EBITDAEarnings before interest/tax$12.7B$12.1B$802M$3.5B
Net IncomeAfter-tax profit$5.3B$7.1B-$275M$2.1B
Free Cash FlowCash after capex$12.9B$5.1B$577M$1.9B
Gross MarginGross profit ÷ Revenue+52.1%+46.0%+18.5%+44.5%
Operating MarginEBIT ÷ Revenue+49.3%+28.8%+5.6%+17.7%
Net MarginNet income ÷ Revenue+30.5%+20.6%-5.0%+12.9%
FCF MarginFCF ÷ Revenue+75.0%+14.7%+10.5%+11.8%
Rev. Growth (YoY)Latest quarter vs prior year-100.0%+8.2%+32.7%+4.8%
EPS Growth (YoY)Latest quarter vs prior year-100.0%+13.4%+19.3%
NEM leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

Evenly matched — NEM and ALB each lead in 3 of 7 comparable metrics.

At 18.0x trailing earnings, NEM trades at a 50% valuation discount to ECL's 36.2x P/E. Adjusting for growth (PEG ratio), LIN offers better value at 1.36x vs NEM's 1.40x — a lower PEG means you pay less per unit of expected earnings growth.

MetricNEM logoNEMNewmont Corporati…LIN logoLINLinde plcALB logoALBAlbemarle Corpora…ECL logoECLEcolab Inc.
Market CapShares × price$127.5B$232.6B$22.7B$74.4B
Enterprise ValueMkt cap + debt − cash$120.4B$254.5B$24.4B$83.2B
Trailing P/EPrice ÷ TTM EPS17.96x34.40x-33.50x36.18x
Forward P/EPrice ÷ next-FY EPS est.11.05x28.12x21.72x31.46x
PEG RatioP/E ÷ EPS growth rate1.40x1.36x
EV / EBITDAEnterprise value multiple9.17x20.04x32.31x23.20x
Price / SalesMarket cap ÷ Revenue5.77x6.84x4.41x4.63x
Price / BookPrice ÷ Book value/share3.75x5.92x2.32x7.66x
Price / FCFMarket cap ÷ FCF17.47x45.70x32.78x39.07x
Evenly matched — NEM and ALB each lead in 3 of 7 comparable metrics.

Profitability & Efficiency

NEM leads this category, winning 8 of 9 comparable metrics.

ECL delivers a 22.0% return on equity — every $100 of shareholder capital generates $22 in annual profit, vs $-3 for ALB. NEM carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to ECL's 0.96x. On the Piotroski fundamental quality scale (0–9), NEM scores 9/9 vs ECL's 5/9, reflecting strong financial health.

MetricNEM logoNEMNewmont Corporati…LIN logoLINLinde plcALB logoALBAlbemarle Corpora…ECL logoECLEcolab Inc.
ROE (TTM)Return on equity+15.6%+17.8%-2.7%+22.0%
ROA (TTM)Return on assets+9.4%+8.3%-1.7%+8.8%
ROICReturn on invested capital+24.9%+11.3%+0.6%+12.7%
ROCEReturn on capital employed+20.7%+13.0%+0.6%+15.8%
Piotroski ScoreFundamental quality 0–99665
Debt / EquityFinancial leverage0.01x0.68x0.34x0.96x
Net DebtTotal debt minus cash-$7.2B$21.9B$1.7B$8.8B
Cash & Equiv.Liquid assets$7.6B$5.1B$1.6B$646M
Total DebtShort + long-term debt$474M$27.0B$3.3B$9.4B
Interest CoverageEBIT ÷ Interest expense50.54x34.52x0.57x9.82x
NEM leads this category, winning 8 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

NEM leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in NEM five years ago would be worth $18,360 today (with dividends reinvested), compared to $12,030 for ECL. Over the past 12 months, ALB leads with a +237.9% total return vs ECL's +5.4%. The 3-year compound annual growth rate (CAGR) favors NEM at 34.9% vs ALB's 2.0% — a key indicator of consistent wealth creation.

MetricNEM logoNEMNewmont Corporati…LIN logoLINLinde plcALB logoALBAlbemarle Corpora…ECL logoECLEcolab Inc.
YTD ReturnYear-to-date+14.0%+17.3%+34.1%+0.6%
1-Year ReturnPast 12 months+112.6%+13.6%+237.9%+5.4%
3-Year ReturnCumulative with dividends+145.5%+41.9%+6.2%+56.7%
5-Year ReturnCumulative with dividends+83.6%+78.1%+31.2%+20.3%
10-Year ReturnCumulative with dividends+271.4%+376.9%+202.4%+142.1%
CAGR (3Y)Annualised 3-year return+34.9%+12.4%+2.0%+16.2%
NEM leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

LIN leads this category, winning 2 of 2 comparable metrics.

LIN is the less volatile stock with a 0.24 beta — it tends to amplify market swings less than ALB's 1.60 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LIN currently trades 96.3% from its 52-week high vs ECL's 85.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricNEM logoNEMNewmont Corporati…LIN logoLINLinde plcALB logoALBAlbemarle Corpora…ECL logoECLEcolab Inc.
Beta (5Y)Sensitivity to S&P 5000.75x0.24x1.60x0.63x
52-Week HighHighest price in past year$134.88$521.28$215.69$309.27
52-Week LowLowest price in past year$48.27$387.78$53.70$249.04
% of 52W HighCurrent price vs 52-week peak+85.3%+96.3%+89.3%+85.2%
RSI (14)Momentum oscillator 0–10046.150.654.638.4
Avg Volume (50D)Average daily shares traded9.2M2.3M2.0M1.4M
LIN leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Evenly matched — LIN and ALB each lead in 1 of 2 comparable metrics.

Analyst consensus: NEM as "Buy", LIN as "Buy", ALB as "Hold", ECL as "Buy". Consensus price targets imply 24.2% upside for ECL (target: $327) vs -0.9% for ALB (target: $191). For income investors, LIN offers the higher dividend yield at 1.20% vs ALB's 0.84%.

MetricNEM logoNEMNewmont Corporati…LIN logoLINLinde plcALB logoALBAlbemarle Corpora…ECL logoECLEcolab Inc.
Analyst RatingConsensus buy/hold/sellBuyBuyHoldBuy
Price TargetConsensus 12-month target$137.50$539.71$190.80$327.11
# AnalystsCovering analysts36284537
Dividend YieldAnnual dividend ÷ price+0.9%+1.2%+0.8%+1.0%
Dividend StreakConsecutive years of raises161512
Dividend / ShareAnnual DPS$1.00$6.00$1.62$2.64
Buyback YieldShare repurchases ÷ mkt cap+1.8%+2.0%0.0%+1.1%
Evenly matched — LIN and ALB each lead in 1 of 2 comparable metrics.
Key Takeaway

NEM leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). LIN leads in 1 (Risk & Volatility). 2 tied.

Best OverallNewmont Corporation (NEM)Leads 3 of 6 categories
Loading custom metrics...

NEM vs LIN vs ALB vs ECL: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is NEM or LIN or ALB or ECL a better buy right now?

For growth investors, Newmont Corporation (NEM) is the stronger pick with 19.

1% revenue growth year-over-year, versus -4. 4% for Albemarle Corporation (ALB). Newmont Corporation (NEM) offers the better valuation at 18. 0x trailing P/E (11. 0x forward), making it the more compelling value choice. Analysts rate Newmont Corporation (NEM) a "Buy" — based on 36 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — NEM or LIN or ALB or ECL?

On trailing P/E, Newmont Corporation (NEM) is the cheapest at 18.

0x versus Ecolab Inc. at 36. 2x. On forward P/E, Newmont Corporation is actually cheaper at 11. 0x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Newmont Corporation wins at 0. 86x versus Linde plc's 1. 11x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — NEM or LIN or ALB or ECL?

Over the past 5 years, Newmont Corporation (NEM) delivered a total return of +83.

6%, compared to +20. 3% for Ecolab Inc. (ECL). Over 10 years, the gap is even starker: LIN returned +376. 9% versus ECL's +142. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — NEM or LIN or ALB or ECL?

By beta (market sensitivity over 5 years), Linde plc (LIN) is the lower-risk stock at 0.

24β versus Albemarle Corporation's 1. 60β — meaning ALB is approximately 565% more volatile than LIN relative to the S&P 500. On balance sheet safety, Newmont Corporation (NEM) carries a lower debt/equity ratio of 1% versus 96% for Ecolab Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — NEM or LIN or ALB or ECL?

By revenue growth (latest reported year), Newmont Corporation (NEM) is pulling ahead at 19.

1% versus -4. 4% for Albemarle Corporation (ALB). On earnings-per-share growth, the picture is similar: Newmont Corporation grew EPS 124. 1% year-over-year, compared to -1. 2% for Ecolab Inc.. Over a 3-year CAGR, NEM leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — NEM or LIN or ALB or ECL?

Newmont Corporation (NEM) is the more profitable company, earning 32.

1% net margin versus -9. 9% for Albemarle Corporation — meaning it keeps 32. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NEM leads at 46. 9% versus 1. 8% for ALB. At the gross margin level — before operating expenses — NEM leads at 49. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is NEM or LIN or ALB or ECL more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Newmont Corporation (NEM) is the more undervalued stock at a PEG of 0. 86x versus Linde plc's 1. 11x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Newmont Corporation (NEM) trades at 11. 0x forward P/E versus 31. 5x for Ecolab Inc. — 20. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ECL: 24. 2% to $327. 11.

08

Which pays a better dividend — NEM or LIN or ALB or ECL?

All stocks in this comparison pay dividends.

Linde plc (LIN) offers the highest yield at 1. 2%, versus 0. 8% for Albemarle Corporation (ALB).

09

Is NEM or LIN or ALB or ECL better for a retirement portfolio?

For long-horizon retirement investors, Linde plc (LIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

24), 1. 2% yield, +376. 9% 10Y return). Albemarle Corporation (ALB) carries a higher beta of 1. 60 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (LIN: +376. 9%, ALB: +202. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between NEM and LIN and ALB and ECL?

Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: NEM is a mid-cap high-growth stock; LIN is a large-cap quality compounder stock; ALB is a mid-cap quality compounder stock; ECL is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

NEM

Quality Mega-Cap Compounder

  • Sector: Basic Materials
  • Market Cap > $100B
  • Net Margin > 18%
  • Dividend Yield > 0.5%
Run This Screen
Stocks Like

LIN

Quality Mega-Cap Compounder

  • Sector: Basic Materials
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 12%
Run This Screen
Stocks Like

ALB

High-Growth Disruptor

  • Sector: Basic Materials
  • Market Cap > $100B
  • Revenue Growth > 16%
  • Dividend Yield > 0.5%
Run This Screen
Stocks Like

ECL

Stable Dividend Mega-Cap

  • Sector: Basic Materials
  • Market Cap > $100B
  • Net Margin > 7%
  • Dividend Yield > 0.5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform NEM and LIN and ALB and ECL on the metrics below

Revenue Growth>
%
(NEM: -100.0% · LIN: 8.2%)
Net Margin>
%
(NEM: 30.5% · LIN: 20.6%)
P/E Ratio<
x
(NEM: 18.0x · LIN: 34.4x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.